This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Pancreatic tumors and cancers are one of the most serious and life-threatening conditions that can affect anyone, regardless of age or gender. Pancreatic cancers usually develop in the pancreas, an organ located in the abdomen that helps with digestion and produces hormones. Pancreatic tumors and cancers can be classified into two major types – exocrine tumors, which are the most common, and neuroendocrine tumors, which are less common but can be more aggressive and difficult to treat. Exocrine tumors are the most common type of pancreatic cancer and the majority of cases are adenocarcinomas, which develop from the cells that line the ducts of the pancreas. Symptoms of exocrine tumors may include pain in the upper abdomen, jaundice, weight loss, and fatigue. Neuroendocrine tumors are much rarer and typically develop from hormone-producing cells in the pancreas. Symptoms of neuroendocrine tumors can include abdominal pain, diarrhoea, and weight loss. Diagnosis of pancreatic tumors and cancers is typically done with imaging tests such as a CT scan or MRI, as well as blood tests and biopsies. Treatment typically includes surgery, chemotherapy, and/or radiation therapy, depending on the type and stage of the cancer. While surgery is often the first-line treatment, it is not always an option depending on the tumor's location, size, and spread. Overall, pancreatic tumors and cancers are serious and life-threatening conditions that require prompt diagnosis, treatment, and follow-up for the best chances of a successful outcome. It is important to discuss any symptoms with your healthcare provider and to seek prompt medical attention if you experience any of the signs or symptoms of pancreatic cancer.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States